Empagliflozin and Cardiovascular Outcomes Across Urine Albumin to Creatinine Ratio Categories: A Systematic Review and Meta-analysis

Ahmed Abdelaziz; Abdelrahman Hafez; Mohamed Abdelaziz; Karim Atta; Basel Abdelazeem; Mustafa Suppah; Leandro Slipczuk; Carl J. Lavie

doi:10.1016/j.mayocp.2024.05.007

Empagliflozin and Cardiovascular Outcomes Across Urine Albumin to Creatinine Ratio Categories: A Systematic Review and Meta-analysis

Ahmed Abdelaziz, Abdelrahman Hafez, Mohamed Abdelaziz, Karim Atta, Basel Abdelazeem, Mustafa Suppah, Leandro Slipczuk, Carl J. Lavie

Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1188-1191
Number of pages	4
Journal	Mayo Clinic Proceedings
Volume	99
Issue number	7
DOIs	https://doi.org/10.1016/j.mayocp.2024.05.007
State	Published - Jul 2024

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.mayocp.2024.05.007

Cite this

@article{9899809746fd4dfcaa1bea3e7a843d95,

title = "Empagliflozin and Cardiovascular Outcomes Across Urine Albumin to Creatinine Ratio Categories: A Systematic Review and Meta-analysis",

author = "Ahmed Abdelaziz and Abdelrahman Hafez and Mohamed Abdelaziz and Karim Atta and Basel Abdelazeem and Mustafa Suppah and Leandro Slipczuk and Lavie, {Carl J.}",

year = "2024",

month = jul,

doi = "10.1016/j.mayocp.2024.05.007",

language = "English (US)",

volume = "99",

pages = "1188--1191",

journal = "Mayo Clinic Proceedings",

issn = "0025-6196",

publisher = "Elsevier Ltd",

number = "7",

}

TY - JOUR

T1 - Empagliflozin and Cardiovascular Outcomes Across Urine Albumin to Creatinine Ratio Categories

T2 - A Systematic Review and Meta-analysis

AU - Abdelaziz, Ahmed

AU - Hafez, Abdelrahman

AU - Abdelaziz, Mohamed

AU - Atta, Karim

AU - Abdelazeem, Basel

AU - Suppah, Mustafa

AU - Slipczuk, Leandro

AU - Lavie, Carl J.

PY - 2024/7

Y1 - 2024/7

UR - http://www.scopus.com/inward/record.url?scp=85196794966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85196794966&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2024.05.007

DO - 10.1016/j.mayocp.2024.05.007

M3 - Article

C2 - 38960500

AN - SCOPUS:85196794966

SN - 0025-6196

VL - 99

SP - 1188

EP - 1191

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

IS - 7

ER -

Empagliflozin and Cardiovascular Outcomes Across Urine Albumin to Creatinine Ratio Categories: A Systematic Review and Meta-analysis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this